Back to Stock Dashboard
Sector:
Healthcare
Add to portfolio
AKAN
Akanda Corp.
CAPPED RATING
Akanda Corp. (AKAN) is rated C- (2.0/5) on Deltasharpe Prism, scored against Healthcare sector peers. Its strongest pillar is Value (B-); its weakest is Momentum (D-). The rating has held at C- for 8 weeks.
Quantitative Factor Evaluation • Updated
Overall Rating
2.0
/ 5.0
C-
Value
B-
Factor Score
3.0
/ 5.0
Growth
C+
Factor Score
2.5
/ 5.0
Profitability
D-
Factor Score
1.1
/ 5.0
Momentum
D-
Factor Score
0.7
/ 5.0
Revisions
C+
Factor Score
2.6
/ 5.0
Prism grades are automated quantitative screens, not buy, sell or hold recommendations, and not investment advice. Data may be delayed or contain errors. Terms
Ratings of B- and above are for members.
Register free to see every rating — your first 2 weeks of Premium are on us.
Register — 2 weeks freeUnderlying Financial Metrics
P/E Ratio
N/A
EV / EBITDA
-2.3
Rev Growth YoY
N/A
Gross Margin
-12.0%
Price Return 3M
-54.5%
Price Return 12M
-92.4%
Catalyst Signal
0.00
Market Cap
$5.8M
TTM Revenue
$662.5K
Price / Sales
8.8
ROE
N/A
Historical Factor Score Progression
Held C- for 8 weeks
| Date | Value | Growth | Profitability | Momentum | Revisions | Overall |
|---|---|---|---|---|---|---|
| 2026-11-17 | B- (3.0) | C+ (2.5) | D- (1.1) | D- (0.7) | C+ (2.6) | C- (2.0) |
| 2026-11-10 | B- (3.0) | C+ (2.5) | D- (1.1) | F (0.3) | C+ (2.6) | C- (1.9) |
| 2026-11-03 | B- (2.9) | C+ (2.5) | D- (1.0) | F (0.3) | C+ (2.7) | C- (1.9) |
| 2026-10-27 | B- (3.0) | C+ (2.5) | D- (1.0) | F (0.4) | C+ (2.6) | C- (1.9) |
| 2026-10-20 | B- (3.0) | C+ (2.5) | D- (1.0) | D- (1.0) | C+ (2.6) | C- (2.0) |
Page
1
of
4